Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?
about
The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathwaysTANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky pre-chylomicrons/VLDLs from the endoplasmic reticulumApolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Pharmacologic inhibition of sphingomyelin synthase (SMS) activity reduces apolipoprotein-B secretion from hepatocytes and attenuates endotoxin-mediated macrophage inflammation.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entrySuccessful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsFrom whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsUp-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat DietProtein disulfide isomerases contribute differentially to the endoplasmic reticulum-associated degradation of apolipoprotein B and other substratesApolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C VirusTanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 CellsApolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse ModelAtypical antipsychotics alter cholesterol and fatty acid metabolism in vitroVery-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth.Lipids and HCV.Virion assembly and release.Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.Regression of Atherosclerosis: The Journey From the Liver to the Plaque and BackGenetic and epigenetic mechanisms of NASH.Current limitations and future opportunities for prediction of DILI from in vitro.Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis.The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles.Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism.Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO).Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.Green fluorescent protein-tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress.Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.A conserved RNA structural element within the hepatitis B virus post-transcriptional regulatory element enhance nuclear export of intronless transcripts and repress the splicing mechanism.Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum.Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100.Functional innate immunity restricts Hepatitis C Virus infection in induced pluripotent stem cell-derived hepatocytes.Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
P2860
Q26824858-D5475783-9418-49BF-A87F-177537484E0CQ28118978-64A98A3A-2543-4F4D-98B4-6BE62A3ADF93Q33858526-4EA5D37C-F4FA-4F1D-8B69-3C95DC63DA2CQ33916433-8B3E7AE6-3FAC-4B25-945C-B85DBF285F2EQ33940346-20D44557-0DB5-4FF4-A639-77E0AC90799FQ34062532-57FAFDE3-DAF0-4F50-94DE-51F97822EFA7Q34416004-38394E3B-E268-4931-AF33-1BC44554BDC9Q34800989-67DF7FC3-9BC8-4A21-9DD9-B9D87FF02D50Q35125004-DD72FA1C-7991-45D1-83BE-A3D891EE1DFEQ35602046-08D1E516-37C5-4520-82C0-5EC172EC4CB9Q35756661-72BD7527-76A1-4080-8B31-5EAB3DBACBF6Q36080826-8A5D1190-CCDE-4A2D-BCB9-4688B8C50CCDQ36129786-796D4E46-A26A-40AE-8354-4C462A254B58Q36233117-5282442A-D50E-40BA-814B-40080784BE61Q36281615-25A42421-C782-4090-9C04-BFF0328B0A84Q36658341-768385E8-DB48-4D97-8DAF-F8D66954FCD7Q36760026-F40F9020-7474-4D9F-9200-07D16E8A8864Q37015738-0D5431E3-D3D6-45A8-8D40-973520585923Q37344324-7B099DBB-4BA6-4D8D-8E90-AB7D618534ADQ38056643-18195639-9EF0-47CD-B788-543DA65C3D46Q38086754-8B2E339A-A910-4D53-B320-276311B2CF85Q38166372-D26986D1-5D75-442C-AE33-7286ED9E012DQ38560870-DB8A9CB2-3B08-4731-B965-EAA7DE7E1A4DQ38673496-187119CE-12B8-4585-BEF7-EC2114FEFF71Q38739197-7DF483C1-5933-4136-BA58-06982748E502Q38816682-9BA995D1-F096-4DA3-B47F-A0B40461AB4AQ38994081-1580C035-F716-4E58-980B-0CEC44B839FCQ39318833-0DCC58DD-3D37-4ACA-A5A9-84F8BA6C2147Q39346744-7D33B8BF-FAFC-443C-9035-39461FBBF84BQ39450330-28A7AB83-D5F8-4FDB-AC35-6FC5D871B5F9Q39558073-750195DD-61D7-48ED-A271-B3620A311B28Q40390599-5582282C-66EB-4076-AEF6-858DC2B3C924Q40813737-A127FCCF-A6BC-4F79-8676-4512A7049BD7Q40932128-821140B4-F970-48E4-8D03-E7FD849ADF70Q41705191-5E2BCD9A-561E-45C7-B74C-5686F9259D59Q42977206-184AB8B9-259D-4AAB-AC7E-2D0A4489493EQ47116322-7EEF4E02-BFE3-47C4-9FE2-11168427EDF9Q47231484-53A50670-CFA4-4676-800A-42A6715BDB5CQ54263654-8AA34DF4-4619-455B-B376-84B9D9E83DD3Q54964965-E733313A-62C9-4872-9C14-0463F473B3AB
P2860
Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@ast
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@en
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@nl
type
label
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@ast
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@en
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@nl
prefLabel
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@ast
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@en
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@nl
P2860
P356
P1476
Huh-7 or HepG2 cells: which is ...... n-B100 assembly and secretion?
@en
P2093
Steven J R Meex
Ursula Andreo
P2860
P304
P356
10.1194/JLR.D008888
P577
2010-10-18T00:00:00Z